Shares of Novo Nordisk in Copenhagen plunged the most in nearly four months after top-line results from a two-year analysis of the evoke and evoke+ Phase 3 trials, a pill version of Ozempic, showed the treatment failed to slow progression in early-stage symptomatic Alzheimer’s disease. The studies, which enrolled 3,808 adults over two years, found […]

By John Liu, Bloomberg markets live reporter and strategist Three things we learned last week: 1. As concerns over an artificial intelligence bubble intensify in US stock markets, the Trump administration is considering options to ease restrictions on chip exports to China. US officials are said to have early discussions on whether to let Nvidia […]

The world’s largest global diversified miner, BHP Group, has abandoned a renewed takeover approach for Anglo American, ending a brief effort to disrupt Anglo’s planned $60-billion merger with Canada’s Teck Resources. BHP confirmed earlier that it had held preliminary discussions with Anglo, but said it was now “no longer considering a combination of the two companies” and […]

Although members of Congress are currently prohibited from trading on nonpublic information courtesy of the 2012 STOCK Act, their routine access to market-moving information in closed-door hearings—and high-profile examples of exceedingly well-timed trades—has kept speculation buzzing. In 2022, for example, then-Speaker Nancy Pelosi’s husband Paul—who owns an investment firm—purchased more than $1 million in Nvidia […]

Authored by Steve Watson via Modernity.news, Rep. Byron Donalds (R-FL) lit into Democrats Friday on Capitol Hill, blasting their viral video urging military mutiny against President Trump as a cynical “grenade” lobbed for clicks and clout—then dismissing their crocodile tears over Trump’s jail threats as “BS” with zero moral high ground. Speaking to reporters amid […]